Providence Therapeutics

Providence Therapeutics

Biotechnology Research

Calgary, Alberta 5,056 followers

Where Hope and Science Intersect

About us

Providence Therapeutics Holdings Inc is a clinical-stage biotechnology company focused on drug development and platform development. The Providence mRNA Medicines platform is comprised of four integrated platforms: 1) mRNA Medicines Platform, 2) NextGen lipid nanoparticles (LNP), 3) Manufacturing Platform and 4) Regulatory Platform. Providence’s mRNA and NextGen LNP platform offer an end-to-end solution for designing codon-optimized ultrapure mRNA that can be formulated in application optimized LNP. The Providence proprietary NextGen LNP, consists of rationally designed lipids that have been tested for suitability for programs in oncology, infectious diseases and gene delivery. Our scalable, efficient platform demonstrates differentiated capabilities in mRNA design, manufacturing, and formulation processes, as well as specific organ and tissue targeting. For more information, please visit providencetherapeutics.com

Website
http://www.providencetherapeutics.com
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Calgary, Alberta
Type
Privately Held
Founded
2015
Specialties
mRNA therapeutics, personalized vaccines, cancer vaccines, lipid nanoparticles, COVID-19 Vaccine, and biotech

Locations

Employees at Providence Therapeutics

Updates

Similar pages

Browse jobs

Funding